The collective data suggested that co-inhibition of EGFR/IGF-1R/CRAF could decrease VemR A375 melanoma cell proliferation to a certain extent through the suppression of the activation of MAPK and/or PI3K/AKT signaling pathways. Here, AKT1 is linked to melanoma.